RecruitingNCT06782308

Tinnitus Patient Preferences Survey


Sponsor

Nicolas Gninenko

Enrollment

500 participants

Start Date

Jan 13, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Individuals aged 18 or older suffering from subjective tinnitus
  • Self-reported or healthcare professional-diagnosed chronic (lasting 3 months or longer), subjective, burdensome tinnitus

Exclusion Criteria2

  • Individuals under 18 years of age
  • Healthy volunteers without tinnitus

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSurvey using a questionnaire.

patients preferences survey


Locations(1)

Neurosoft Bielectronics US Inc.

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06782308


Related Trials